News|Articles|December 13, 2023
Harnessing cell line engineering capabilities to enhance biotherapeutic products
Author(s)Revvity
Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
3
Share Your Perspective on the Commissioner’s National Priority Vouchers Program
4
PharmTech Weekly News Roundup — Week of November 10, 2025
5
